GlaxoSmithKline has brushed aside Brexit jitters and announced that it is pumping £275m into its three UK manufacturing sites, dubbing the UK an "attractive location".

Drug maker GlaxoSmithKline today warned of job losses as it announced cost-cutting plans to offset falling sales of diabetes treatment Avandia.

The British-Irish inter-parliamentary body is due to hold its latest biannual meeting in the British town of Ware this week.